FDA Letter Recommends Removing Some Sapien M3 Delivery Systems
The FDA is aware Edwards Lifesciences issued a letter recommending removal of some delivery systems used for Sapien M3 transcatheter mitral valve replacement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.